Business Context and Reporting Period
Company: OraSure Technologies, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: August 6, 2004
Principal Executive Offices: Bethlehem, Pennsylvania
Key Financial Metrics
This filing reports a specific transaction rather than periodic financial statements. The document does not provide revenue, profit, cash flow, margins, debt, or liquidity figures for the reporting period.
- Transaction Value: $4 million purchase order.
- Product/Service: OraQuick Rapid HIV Tests and HIV confirmatory test services.
- Counterparty: Substance Abuse and Mental Health Services Administration (SAMHSA).
Material Changes
The filing announces the receipt of a significant purchase order from a federal agency. No comparative financial data or prior period metrics are included in this document to assess material changes in overall financial condition.
Guidance, Outlook, and Risks
Management Commentary: The company issued a press release (Exhibit 99) confirming the order. The filing incorporates this press release by reference.
Outlook/Risks: The filing text does not provide specific forward-looking guidance, risk factors, or contingencies beyond the announcement of the order itself.
Investor Verification Checklist
- Verify the terms and duration of the $4 million purchase order with SAMHSA.
- Confirm the expected revenue recognition schedule for the OraQuick tests and confirmatory services.
- Review the full text of the press release attached as Exhibit 99 for additional details on the contract scope.
- Check subsequent filings for updates on the fulfillment of this order and its impact on quarterly results.